I'm sure they are referring to PTC124 - a drug currently in development.
It's been shown to partially restore CFTR function for nonsense mutations.
From the <a target=_blank class=ftalternatingbarlinklarge href="http://www.ptcbio.com/3.1.1_generic_disorders.aspx">website</a> of PTC Theraputics:
<div class="FTQUOTE"><begin quote>PTC124 is a novel, orally administered small-molecule compound that targets a particular genetic alteration known as a nonsense mutation. Genetic disorders occur as a consequence of mutations in an individual's DNA. Nonsense mutations are alterations in the DNA that, when transcribed into mRNA, introduce a premature translation termination codon. This change halts the ribosomal translation process at an earlier site than normal, producing a truncated, non-functional protein. PTC is developing PTC124 for the treatment of genetic disorders in which a nonsense mutation is the cause of the disease.</end quote></div>
In simple terms, a nonsense mutation (ends in X) is like tossing a stop sign in the middle of the freeway. The cell is making the protein (driving the freeway), it sees the stop sign and stops - even though it doesn't belong there. This drug tells the cell to ignore the stop sign and keep driving, so it completes the CTFR protein. For those who are visual learners - there's a nifty picture on PTC's website.